Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
CalAmp Corp (CAMP) Insider Trading Activity
Healthcare • Biotechnology • 58 employees
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Total Value
$71,399,944.00
Total Shares
6,490,904
Average Trade Value
$8,924,993.00
Most Active Insider
Enavate Sciences Gp, Llc
Total Activity: $14,999,996
Largest Single Transaction
$14,999,996
by Enavate Sciences Gp, Llc on Oct 15, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Oct 15, 2024 | 181,818 | $1,999,998 | 1,579,885 (+11.5%) | Purchase | ||
| Oct 15, 2024 | 909,090 | $9,999,990 | 2,625,145 (+34.6%) | Purchase | ||
|
Director, 10% Owner
|
Oct 15, 2024 | 909,090 | $9,999,990 | 909,090 (+100.0%) | Purchase | |
| Oct 15, 2024 | 763,636 | $8,399,996 | 763,636 (+100.0%) | Purchase | ||
| Oct 15, 2024 | 909,090 | $9,999,990 | 909,090 (+100.0%) | Purchase | ||
| Oct 15, 2024 | 545,454 | $5,999,994 | 545,454 (+100.0%) | Purchase | ||
|
Director, 10% Owner
|
Oct 15, 2024 | 909,090 | $9,999,990 | 2,625,145 (+34.6%) | Purchase | |
| Oct 15, 2024 | 1,363,636 | $14,999,996 | 3,785,802 (+36.0%) | Purchase |